Peptide questions · Pemvidutide

How long does pemvidutide take to work?

Reviewed Evidence: ModeratePublished by PepVault

Pemvidutide’s onset is days–2 weeks, its peak effect comes at 48+ weeks, and its typical duration is ongoing, by the library’s timeline (backed by moderate evidence).

The timeline’s basis: Phase 2 trials (MOMENTUM, company-reported; IMPACT, Lancet 2025) and fatty-liver trials (J Hepatol 2025, JHEP Rep 2025). Not approved.

Pemvidutide week by week

The library places five of its research notes on pemvidutide on the days they cover, from day 1 to day 336: 5 on randomized trials.

Day 1 is the first day of a run. Each bar is one of the library’s research notes, placed on the days it covers.

The pemvidutide notes by day
WhenThe noteEvidence
Days 1–84 (weeks 1–12)No ramp at this doseRandomized trial
Days 1–84 (weeks 1–12)Most side effects come earlyRandomized trial
Days 1–112 (weeks 1–16)The top dose, after a short rampRandomized trial
Days 57–168 (weeks 9–24)Liver fat drops faster than weightRandomized trial
Days 169–336 (weeks 25–48)Most of the loss is fatRandomized trial
A smiling man in a grey t-shirt in his living room, holding his phone

Model. Individual results vary.

PepVault for iPhone

Track pemvidutide in PepVault

Log each dose and your weekly check-ins, and see your own weeks add up.

Download on the App Store

7 days free on the yearly plan for new subscribers.

The pemvidutide timeline’s milestones

The library’s timeline for pemvidutide marks 4 points from week 1 to week 48, backed by moderate evidence overall.

  • Week 1: Started without a ramp at 1.2 or 1.8 mg in its trials; in MOMENTUM, most stops for side effects came in the first 16 weeks
  • Week 12: In a 12-week fatty-liver trial, liver fat fell by about half to two-thirds
  • Week 24: In IMPACT (people with MASH), steatohepatitis resolved on biopsy in over half, vs 20% on placebo
  • Week 48: MOMENTUM: 10.3% to 15.6% average loss by dose, still falling on 2.4 mg

The weeks are the library’s reference timeline from studies and reported use, not a promise of what any one person will notice.

Why pemvidutide takes that long

The library states no half-life with a number for pemvidutide (it says: “Not published: built for weekly dosing (its EuPort domain binds albumin to slow clearance), but no human half-life has been released”), so this page can’t work out a build-up; the timing rests on the notes above.

The notes on pemvidutide follow the trials’ dose steps, 1.2mg, 1.8mg and 2.4mg, so the later weeks also describe higher steps than the first ones; these are steps from studies, not a schedule for a person.

Pemvidutide against other metabolic & GLP-1 compounds

The library holds an onset-and-peak timeline for 21 metabolic & GLP-1 compounds, pemvidutide among them; 15 of the others share its onset of days–2 weeks.

When metabolic & GLP-1 compounds start to act and peak, by the library’s timelines
CompoundOnsetPeak effect
SemaglutideDays–2 weeks60–68 weeks
TirzepatideDays–2 weeks72+ weeks
RetatrutideDays–2 weeks48+ weeks
DulaglutideDays–2 weeks24–52 weeks (glucose)
ExenatideFirst dose (after-meal glucose)24–30 weeks (HbA1c)
Setmelanotide1–2 weeks (hunger)52 weeks (BMI)
OrforglipronDays–2 weeks72 weeks (trial endpoint)
SurvodutideDays–2 weeks76 weeks (trial endpoint)
MazdutideDays–2 weeks48–60 weeks
PemvidutideDays–2 weeks48+ weeks
CagrilintideDays–2 weeks26–68 weeks (trial endpoints)
PramlintideFirst meal (fullness, after-meal glucose)16–52 weeks (weight, HbA1c)
CagriSemaDays–2 weeks68+ weeks
EloralintideDays–2 weeks48 weeks (phase 2 endpoint)
PetrelintideDays–2 weeks42 weeks (phase 2, still falling)
AmycretinDays–2 weeks36 weeks (longest trial so far)
VK2735Days–2 weeks78 weeks (phase 3 endpoint, not yet read out)
EnicepatideDays–2 weeks48 weeks (phase 2 endpoint, no plateau)
EcnoglutideDays–2 weeks48 weeks (phase 3, no plateau)
EfinopegdutideWeeks24–52 weeks (trial endpoints)
SLU-PP-332Unknown in peopleUnknown in people

Questions people ask

How long does pemvidutide take to work?

Pemvidutide’s onset is days–2 weeks, its peak effect comes at 48+ weeks, and its typical duration is ongoing, by the library’s timeline (backed by moderate evidence).

When does pemvidutide reach its peak effect?

By the library’s timeline, pemvidutide’s peak effect comes at 48+ weeks, backed by moderate evidence.

How long is pemvidutide usually run?

The library’s timeline gives pemvidutide’s typical duration as ongoing; its cycle note says: Continuous weekly dosing in all its trials (12 to 48 weeks); no data on stopping or cycling.

What does the library say about the first days on pemvidutide?

Its first note on pemvidutide, for days 1–84 (weeks 1–12), is “No ramp at this dose”, resting on randomized trials.

More on pemvidutide

Track it in the app

PepVault for iPhone

Track pemvidutide in PepVault

Log each dose and your weekly check-ins, and see your own weeks add up.

Download on the App Store

7 days free on the yearly plan for new subscribers.

Explore the live demo